期刊文献+

改造软胶囊生产过程中的独立转笼结构 被引量:2

Transforming of independent rotor cage in the process of soft capsules production
下载PDF
导出
摘要 目的对独立转笼的笼身结构与电机齿轮进行改造,提升设备性能,从而达到工艺优化,产品质量稳定。方法改造独立转笼的笼身结构,将独立转笼内部导轨拆除,将特弗龙材质的棒材加工成20 cm块状,然后不规则的分布装在转笼内壁。同时将主动齿轮与被动齿轮进行互换。结果通过改造,将丸子在独立转笼滞留的时间由4 min降为1 min,减少丸子变形问题。增加不规则特氟龙导条很好地改变了丸子运行轨迹,解决了丸子在转笼结块黏的问题,独立转笼清洁时间也从原来的30 min降为10 min。结论改造后的独立转笼更适合软胶囊产品的生产,并且减少了废丸的产生,提高独立转笼清洗效率。 Objective To modify the cage structure and motor gear of the independent cage and improve the performance of the equipment, so as to optimize the process and achieve stable product quality. Methods The independent rotor cage was modified, and the inner guide rail of independent rotor cage was dismantled. The Tefulong bars were processed into 20 cm bulks, and then they were installed on the inner wall of the cage by irregular distribution. Also the active gear and the passive gear were interchanged. Results Through equipment modification, the retention time of pills in independent rotor cage was reduced from 4 min to 1 min, which reduced the problem of meatball deformation. The addition of irregular Tefulong bars changed pill trajectory well, and the problem of agglomeration and sticking of pills in rotary cage were solved. The cleaning time of the independent cage was reduced from 30 min to 10 min. Conclusion The independent rotary cage after modification is more suitable for the production of soft capsule products, which reduces the production of waste pills and improves the efficiency of independent rotor cage cleaning.
出处 《食品安全质量检测学报》 CAS 2017年第12期4832-4835,共4页 Journal of Food Safety and Quality
关键词 独立转笼 软胶囊 齿轮 independent rotor cage soft capsule gear
  • 相关文献

参考文献14

二级参考文献34

  • 1张庆斌.包装行业的设备改造浅述[J].科技资讯,2008,6(19). 被引量:3
  • 2王建军,王连泽,刘成文.旋风分离器排气管内流动分析及减阻机理[J].过程工程学报,2005,5(3):251-254. 被引量:18
  • 3杜妍辰,王树林.颗粒在涡轮式分级机分级轮中的运动轨迹[J].化工学报,2005,56(5):823-828. 被引量:26
  • 4罗青波.我国软胶囊制剂的现状与出路[J].上海医药情报研究,1995(1):13-14. 被引量:5
  • 5[3]Curtis JJ. Differences in bioavailability between oral cyclosporine formulations in maintenance renal transplant patients filiation. Am J Kidney Dis, 1999, 34(5): 869
  • 6[4]Min DI. Bioavailability and patient acceptance of cyclosporine soft geltin capsules in renal allograft recipients. Ann Pharmacother, 1992,26(2): 175
  • 7[5]Kovarik JM.Bioequivalence of soft gelatin capsules and oral solution of a new cyclosporine formulation. Pharmacotherapy, 1993,13(6): 613
  • 8[6]Sadler BM.Safety and pharmacokinetics of amprenavir (141W94),a human immunodeficiency virus (HIV) type 1 protease inhibitor, following oral administration of single doses to HIV-infected adults. Antimicrob Agents Chemother, 1999,43(7): 1686
  • 9[7]Hong SS. Accelerated oral absorption of gliclazide in human subjects from a soft gelatin capsule containing a PEG 400 suspension of gliclazide. J Control Release, 1998, 1251(2~3): 185
  • 10[8]Takahashi M. Studies on dissolution tests for soft gelatin capsules by the rotating dialysis cell (RDC) method. Ⅵ.Preparation and evaluation of ibuprofen soft gelatin capsule. Chem Pharm Bull (Tokyo),1995,43(8): 1398

共引文献68

同被引文献15

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部